ResMed Inc (RMD)
178.81
+1.20
(+0.68%)
USD |
NYSE |
Apr 19, 16:00
178.81
0.00 (0.00%)
After-Hours: 20:00
ResMed Debt to Equity Ratio: 0.2737 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.2737 |
September 30, 2023 | 0.3203 |
June 30, 2023 | 0.349 |
March 31, 2023 | 0.4033 |
December 31, 2022 | 0.4817 |
September 30, 2022 | 0.2317 |
June 30, 2022 | 0.2307 |
March 31, 2022 | 0.2076 |
December 31, 2021 | 0.2162 |
September 30, 2021 | 0.2662 |
June 30, 2021 | 0.2271 |
March 31, 2021 | 0.2698 |
December 31, 2020 | 0.2882 |
September 30, 2020 | 0.3944 |
June 30, 2020 | 0.471 |
March 31, 2020 | 0.6102 |
December 31, 2019 | 0.5755 |
September 30, 2019 | 0.5763 |
June 30, 2019 | 0.6133 |
March 31, 2019 | 0.6608 |
December 31, 2018 | 0.6122 |
September 30, 2018 | 0.2787 |
June 30, 2018 | 0.1367 |
March 31, 2018 | 0.3919 |
December 31, 2017 | 0.5046 |
Date | Value |
---|---|
September 30, 2017 | 0.4971 |
June 30, 2017 | 0.5502 |
March 31, 2017 | 0.6299 |
December 31, 2016 | 0.6833 |
September 30, 2016 | 0.6618 |
June 30, 2016 | 0.692 |
March 31, 2016 | 0.2603 |
December 31, 2015 | 0.2635 |
September 30, 2015 | 0.3427 |
June 30, 2015 | 0.1894 |
March 31, 2015 | 0.2998 |
December 31, 2014 | 0.2831 |
September 30, 2014 | 0.2273 |
June 30, 2014 | 0.1711 |
March 31, 2014 | 0.2341 |
December 31, 2013 | 0.2659 |
September 30, 2013 | 0.2132 |
June 30, 2013 | 0.1868 |
March 31, 2013 | 0.1928 |
December 31, 2012 | 0.1718 |
September 30, 2012 | 0.1565 |
June 30, 2012 | 0.156 |
March 31, 2012 | 0.1467 |
December 31, 2011 | 0.1451 |
September 30, 2011 | 0.0866 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2076
Minimum
Mar 2022
0.6133
Maximum
Jun 2019
0.3687
Average
0.3203
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Stryker Corp | 0.6989 |
Boston Scientific Corp | 0.4718 |
Integer Holdings Corp | 0.6319 |
Haemonetics Corp | 0.9229 |
Insulet Corp | 1.932 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 6.905B |
Total Liabilities (Quarterly) | 2.423B |
Shareholders Equity (Quarterly) | 4.482B |
Current Ratio | 3.112 |
Net Debt Paydown Yield | -0.34% |